A Study of Tpeak-Tend/QT Interval Ratio in Predicting Heart Failure in ST-Elevation Myocardial Infarction and Its

Sharan Badiger1, Venugopal Hanumappa1, Avinash V Jugati1

  • 1General Medicine, Shri B. M. Patil Medical College Hospital and Research Centre, Bijapur Lingayat District Education (Deemed to be University), Vijayapura, IND.

Cureus
|October 4, 2024
PubMed

Insights

The Tpeak-Tend/QT interval ratio, a measure of repolarization dispersion, is elevated in ST-elevation myocardial infarction (STEMI) patients who develop heart failure. This ECG marker, along with NT-proBNP, can predict major adverse cardiac events.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Biomarker Research

Background:

  • ST-elevation myocardial infarction (STEMI) is a leading cause of global mortality.
  • The Tpeak-Tend/QT interval on ECG reflects left ventricular repolarization dispersion.
  • Prolonged Tpeak-Tend/QT may indicate adverse cardiac events, including heart failure and arrhythmias.

Purpose of the Study:

  • To evaluate the predictive value of the Tpeak-Tend/QT interval ratio for major adverse cardiac events (MACE), specifically heart failure, in STEMI patients.
  • To examine the correlation between the Tpeak-Tend/QT interval ratio and NT-proBNP levels in STEMI patients.
  • To assess the utility of ECG-derived Tpeak-Tend/QT ratio in conjunction with NT-proBNP for MACE prediction.

Main Methods:

  • A cross-sectional study involving 45 STEMI patients was conducted.
  • Patients were divided into two groups based on Tpeak-Tend/QT ratio (< 0.3 and > 0.3).
  • Exclusion criteria included non-STEMI, valvular heart disease, bundle branch block, and pacemakers. Patients were monitored for heart failure during hospitalization.

Main Results:

  • Out of 45 patients, 14 experienced MACE (heart failure).
  • Among those with MACE, 12 patients (85%) had a Tpeak-Tend/QT ratio > 0.3 and NT-proBNP levels > 900 pg/mL.
  • A statistically significant association was found between an elevated Tpeak-Tend/QT interval ratio and increased NT-proBNP levels in STEMI patients who developed heart failure.

Conclusions:

  • Elevated Tpeak-Tend/QT interval ratio and NT-proBNP levels are associated with heart failure development in STEMI patients.
  • The Tpeak-Tend/QT interval ratio, derived from ECG, shows promise as a predictive marker for MACE in STEMI.
  • Combining ECG Tpeak-Tend/QT ratio with NT-proBNP may enhance MACE prediction in STEMI patients.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
2.2K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
8
Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
177
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
63